Question

In: Biology

1. What is secreted from both natural killer (NK) cells and cytotoxic T (TC) cells from...

1. What is secreted from both natural killer (NK) cells and cytotoxic T (TC) cells from holes in the cell membranes leading to the eventual destruction of the target?

a) Lysomes

b) Perforin

c) Complement

d) Bacteriocin

2. What is the name for a mutagen that insets itself between 2 base pairs so that an extra base is added during DNA replication? Ethidium bromide DNA  is an example.

  1. Base analog
  2. Transposon
  3. Ionizing
  4. Intercalating agent
  1. Which of the following is an example of a conditionally lethal mutation?
  1. Inversion
  2. Temperature-sensitive mutation
  3. Translocation
  4. Thymine-thymine dimer
  1. Insertion equals mutation for all biological mutagens targeting bacteria
  1. True
  2. False
  1. Which term below describes cells that can take up DNA and be transformed? These cells can be generated in the lab using CaCl2, glycerol, and cold temperature
  1. Virulent
  2. Competent
  3. Reactive
  4. Compatible

Solutions

Expert Solution

1.

Perforin, a protein molecule secreted by T-cell and NK cell creates pores in the target cell and kill it eventually. Hence perforin is the correct answer.

2.

Intercalating agents are flat molecules insert between bases and polymerase gets fooled and add a base against these intercalating agents and hence cause mutation. Hence correct option is intercalating agents.

3.

Conditionally lethal mutations are those mutations under certain environmental conditions, there will be mutations leading to death. But under normal conditions cells survive. Example is temperature sensitive mutations. Hence correct option is temperature sensitive mutations.

4.

Transposons are example of biological mutagens which translocate in the DNA and insert itself causing mutation. Hence the statement is true.

5.

Making a cell to take up a surrounding DNA by providing certain environmental conditions such as cold temperature, calcium chloride etc., Known as competent cells. Hence correct option is competent cells.


Related Solutions

Compare and contrast the immune response of NK cells and cytotoxic T cells during primary infection...
Compare and contrast the immune response of NK cells and cytotoxic T cells during primary infection and subsequent infections. Include a comment on the magnitude, kinetics and mechanism of activation observed
In what ways do NK cells differ from, and in what ways do they resemble cytotoxic...
In what ways do NK cells differ from, and in what ways do they resemble cytotoxic T cells?
How do natural killer cells differ from macrophages?
How do natural killer cells differ from macrophages? Give details.
1. Which cells "costimulate" cytotoxic T cells and B cells by secreting cytokines? 2. What are...
1. Which cells "costimulate" cytotoxic T cells and B cells by secreting cytokines? 2. What are the functions of lymph nodes? What are germinal centers? 3. What is meant by the terms "memory" and "specificity" as they pertain to immunity?
1- Cytotoxic T cells recognize and kill host cells infected by viruses. They recognize these cells...
1- Cytotoxic T cells recognize and kill host cells infected by viruses. They recognize these cells by the foreign antigen displayed on the host cell’s:                MHC I molecules                MHCII molecules                toll like receptors 2- Clonal selection:                can be caused by vaccinations                explains why the immune system responds stronger to a second infection than a first                results in antibody specificity following a bacterial infection                all of the above 3- Which of the following describes...
Which of the following are antigen-presenting cells? Macrophages B cells Cytotoxic T cells All of these...
Which of the following are antigen-presenting cells? Macrophages B cells Cytotoxic T cells All of these choices are correct answers. Only the first and second choices are correct answers.
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after 20...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that...
There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after 20...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and...
(20.48) There is evidence that cytotoxic T lymphocytes (T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investigated the use of a T cell-engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts (1000 per microliter) at baseline (beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference (after...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT